GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BrightPath Biotherapeutics Co Ltd (TSE:4594) » Definitions » Price-to-Tangible-Book

BrightPath Biotherapeutics Co (TSE:4594) Price-to-Tangible-Book : 5.03 (As of May. 05, 2024)


View and export this data going back to 2015. Start your Free Trial

What is BrightPath Biotherapeutics Co Price-to-Tangible-Book?

As of today (2024-05-05), BrightPath Biotherapeutics Co's share price is 円60.00. BrightPath Biotherapeutics Co's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was 円11.92. Hence, BrightPath Biotherapeutics Co's Price to Tangible Book Ratio of today is 5.03.

The historical rank and industry rank for BrightPath Biotherapeutics Co's Price-to-Tangible-Book or its related term are showing as below:

TSE:4594' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.6   Med: 3.18   Max: 10.11
Current: 5.03

During the past 9 years, BrightPath Biotherapeutics Co's highest Price to Tangible Book Ratio was 10.11. The lowest was 1.60. And the median was 3.18.

TSE:4594's Price-to-Tangible-Book is ranked worse than
72.18% of 1222 companies
in the Biotechnology industry
Industry Median: 2.715 vs TSE:4594: 5.03

A closely related ratio is called PB Ratio. As of today, BrightPath Biotherapeutics Co's share price is 円60.00. BrightPath Biotherapeutics Co's Book Value per Sharefor the quarter that ended in Dec. 2023 was 円11.92. Hence, BrightPath Biotherapeutics Co's P/B Ratio of today is 5.03.


BrightPath Biotherapeutics Co Price-to-Tangible-Book Historical Data

The historical data trend for BrightPath Biotherapeutics Co's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BrightPath Biotherapeutics Co Price-to-Tangible-Book Chart

BrightPath Biotherapeutics Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only 2.54 2.82 2.80 2.25 6.90

BrightPath Biotherapeutics Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.44 6.90 6.53 8.44 7.30

Competitive Comparison of BrightPath Biotherapeutics Co's Price-to-Tangible-Book

For the Biotechnology subindustry, BrightPath Biotherapeutics Co's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BrightPath Biotherapeutics Co's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BrightPath Biotherapeutics Co's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where BrightPath Biotherapeutics Co's Price-to-Tangible-Book falls into.



BrightPath Biotherapeutics Co Price-to-Tangible-Book Calculation

BrightPath Biotherapeutics Co's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Dec. 2023 )
=60.00/11.918
=5.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


BrightPath Biotherapeutics Co Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of BrightPath Biotherapeutics Co's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


BrightPath Biotherapeutics Co (TSE:4594) Business Description

Traded in Other Exchanges
N/A
Address
2-2-4 Kojimachi, Kojimachi Central Building 7th Floor, Chiyoda-ku, Tokyo, JPN
BrightPath Biotherapeutics Co Ltd is a biopharmaceutical venture company. It is engaged in developing novel cancer immunotherapeutics. Its products include two candidate products: ITK-1 and GRN-1201 which are in the clinical trial stage.

BrightPath Biotherapeutics Co (TSE:4594) Headlines

No Headlines